Related Experiment Video
Updated: May 16, 2026

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
Sex and gender differences in myocarditis and dilated cardiomyopathy
Insights
Sex hormones and genetic variations influence heart disease, impacting outcomes in dilated cardiomyopathy (DCM) between men and women. This review explores immune responses and emerging treatments for women with DCM.
Area of Science:
- Cardiology
- Immunology
- Genetics
Background:
- Nonischemic dilated cardiomyopathy (DCM) is a significant global health issue.
- Myocarditis is a primary cause of acute DCM, affecting both sexes.
- Evidence indicates sex-based differences in DCM pathogenesis and prognosis.
Purpose of the Study:
- To provide a contemporary overview of immune mediators in myocarditis.
- To examine the influence of sex hormones on acute cardiac injury and chronic DCM risk.
- To highlight knowledge gaps in managing acute DCM in women and discuss novel therapies.
Main Methods:
- Review of current clinical and experimental evidence on myocarditis and DCM.
- Analysis of the role of innate and adaptive immune responses.
- Exploration of sex hormone and genetic variation impacts on DCM.
Main Results:
- Sex hormones modulate the heart's response to injury, influencing chronic DCM risk.
- Genetic variations may contribute to epidemiological and survival differences between sexes.
- Sex-specific factors affect left ventricular recovery and overall survival.
Conclusions:
- Understanding sex differences in DCM is crucial for effective management.
- Further research is needed on managing acute DCM in women.
- Emerging therapies, like bromocriptine for peripartum cardiomyopathy, show promise.
Abstract:
Heart failure due to nonischemic dilated cardiomyopathy (DCM) contributes significantly to the global burden of cardiovascular disease. Myocarditis is, in turn, a major cause of acute DCM in both men and women. However, recent clinical and experimental evidence suggests that the pathogenesis and prognosis of DCM differ between the sexes. This seminar provides a contemporary perspective on the immune mediators of myocarditis, including interdependent elements of the innate and adaptive immune response. The heart's acute response to injury is influenced by sex hormones that appear to determine the subsequent risk of chronic DCM. Preliminary data suggest additional genetic variations may account for some of the differences in epidemiology, left ventricular recovery, and survival between men and women. We highlight the gaps in our knowledge regarding the management of women with acute DCM and discuss emerging therapies, including bromocriptine for the treatment of peripartum cardiomyopathy.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Myocarditis III: Medical Management

